IDH2 and acute myeloid leukemia: The study of Lin et al. indicated that mutations in IDH1 did not significantly increase the risk of transformation into acute leukemia, while the presence of IDH2 mutation in MDS cases was associated with an increased risk of evolution to AML (p = 0.004) [58].